{
  "ticker": "LLY",
  "target_date": "2025-07-23",
  "actual_date": "2025-07-23",
  "collected_at": "2025-12-08T12:03:01.078539",
  "price": {
    "open": 777.15,
    "high": 797.17,
    "low": 774.24,
    "close": 795.97021484375,
    "volume": 2683600,
    "change_1d_pct": 2.89,
    "change_7d_pct": -0.06,
    "change_30d_pct": 3.25
  },
  "technicals": {
    "rsi_14": 55.9,
    "sma_20": 778.69,
    "sma_50": 765.38,
    "macd": 0.098,
    "macd_signal": 0.134,
    "macd_histogram": -0.036,
    "bb_upper": 801.06,
    "bb_lower": 756.33,
    "price_vs_sma20_pct": 2.22,
    "price_vs_sma50_pct": 4.0,
    "volume_ratio": 0.9
  },
  "fundamentals": {
    "market_cap": 892082061312,
    "pe_ratio": 48.756493,
    "forward_pe": 43.915268,
    "price_to_book": 37.46687,
    "price_to_sales": 15.013212,
    "profit_margin": 30.99,
    "operating_margin": 48.29,
    "roe": 96.47,
    "roa": 17.6,
    "revenue_growth": 53.9,
    "earnings_growth": 480.4,
    "debt_to_equity": 178.516,
    "current_ratio": 1.546,
    "quick_ratio": 0.724,
    "dividend_yield": 59.0,
    "fifty_two_week_high": 1111.99,
    "fifty_two_week_low": 623.78,
    "fifty_day_avg": 911.5326,
    "two_hundred_day_avg": 811.9354,
    "analyst_target": 1056.7045,
    "analyst_recommendation": "buy",
    "num_analysts": 27,
    "sector": "Healthcare",
    "industry": "Drug Manufacturers - General",
    "pct_from_52w_high": -10.51,
    "pct_from_52w_low": 59.53
  },
  "macro": {
    "spy": {
      "price": 632.46,
      "change_1d_pct": 0.85,
      "change_7d_pct": 1.94
    },
    "vix": {
      "level": 15.37,
      "signal": "NORMAL"
    },
    "treasury_10y": {
      "yield_pct": 4.39
    },
    "dollar_index": {
      "level": 97.21
    },
    "gold": {
      "price": 3394.1
    },
    "regime": "BULL_NORMAL"
  },
  "news": [
    {
      "headline": "Eli Lilly & Co. stock outperforms competitors on strong trading day",
      "source": "MarketWatch",
      "datetime": 1753288260,
      "summary": "Eli Lilly & Co. stock outperforms competitors on strong trading day",
      "url": "https://finnhub.io/api/news?id=f3b307c9150515a3bec58103ddcc923f1940e46cca1c0105b4185ff1f35f1e57"
    },
    {
      "headline": "Eli Lilly Advances Pipeline and Gene Focus With Verve Acquisition",
      "source": "Yahoo",
      "datetime": 1753282890,
      "summary": "Eli Lilly and Company (NYSE:LLY) is one of the 13 Best Low Risk High Growth Stocks to Buy. Amid carrying on new studies, the company has agreed to acquire Verve Therapeutics. Eli Lilly and Company (NYSE:LLY) is a research-driven pharmaceutical leader headquartered in Indiana. With a 150-year history",
      "url": "https://finnhub.io/api/news?id=6dbc183d7b7d58c46b36e5588677b7a9da6fb499a629d3350c98eac7fc3991c7"
    },
    {
      "headline": "Jim Cramer on Eli Lilly: \u201cIt Needs Breakthroughs in New Areas\u201d",
      "source": "Yahoo",
      "datetime": 1753282527,
      "summary": "Eli Lilly and Company (NYSE:LLY) is one of the stocks that Jim Cramer shed light on. While Cramer still backed the company, he did express uncertainty about its future as he stated: \u201cWhat I\u2019m thinking, as someone who owns Eli Lilly for the Charitable Trust and who wishes I owned PepsiCo, is that the",
      "url": "https://finnhub.io/api/news?id=0a17951ac7efc7f365573387725281746f50a4b9e91c1061dd042070778aae84"
    },
    {
      "headline": "Jim Cramer Says \u201cWe Should be in ConocoPhillips\u201d",
      "source": "Yahoo",
      "datetime": 1753282515,
      "summary": "ConocoPhillips (NYSE:COP) is one of the stocks that Jim Cramer shed light on. When a caller asked about the company during the lightning round, Cramer commented: \u201cAll right. Buy COP. Let me tell you, I just told Jeff Marks, my partner for the club, that we\u2019re in the wrong one now. Coterra is not del",
      "url": "https://finnhub.io/api/news?id=a206bf66976e95e934f9f10cd41e0ba0c03cbe17a0345292526c7f8cdd1cb705"
    },
    {
      "headline": "Jim Cramer Says He Does Not Want Novo Nordisk Due to Tariffs",
      "source": "Yahoo",
      "datetime": 1753282507,
      "summary": "Novo Nordisk A/S (NYSE:NVO) is one of the stocks that Jim Cramer shed light on. A caller asked about the stock\u2019s status, and Cramer replied: \u201cI want you to know I don\u2019t want Novo Nordisk\u2026 and the reason that is because if there\u2019s going to be talk about tariffs on foreign drugs versus Eli Lilly, [\u2026]",
      "url": "https://finnhub.io/api/news?id=a4ac0a0a1099c53e0a29ca106d30c905029a01a3ed9621e788557029780ea3a8"
    }
  ],
  "news_count": 5,
  "sec_filings": [
    {
      "form": "4",
      "date": "2025-07-22",
      "description": "xslF345X05/wk-form4_1753219662.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000196/xslF345X05/wk-form4_1753219662.xml"
    },
    {
      "form": "4",
      "date": "2025-07-22",
      "description": "xslF345X05/wk-form4_1753217727.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000194/xslF345X05/wk-form4_1753217727.xml"
    },
    {
      "form": "4",
      "date": "2025-07-22",
      "description": "xslF345X05/wk-form4_1753216439.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000188/xslF345X05/wk-form4_1753216439.xml"
    },
    {
      "form": "4",
      "date": "2025-07-22",
      "description": "xslF345X05/wk-form4_1753215735.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000184/xslF345X05/wk-form4_1753215735.xml"
    },
    {
      "form": "4",
      "date": "2025-07-22",
      "description": "xslF345X05/wk-form4_1753215620.xml",
      "url": "https://www.sec.gov/Archives/edgar/data/59478/000005947825000182/xslF345X05/wk-form4_1753215620.xml"
    }
  ],
  "sec_filings_count": 5,
  "data_quality": {
    "has_price": true,
    "has_technicals": true,
    "has_fundamentals": true,
    "has_macro": true,
    "has_news": true,
    "has_sec_filings": true
  }
}